"emergency-use-listing"

Hyderabad: The World Health Organization (WHO) tweeted on Tuesday that WHO and an independent group of experts will meet next week to carry out the risk/benefit assessment and come to a final decision whether to grant Emergency Use Listing (EUL) to Covaxin. Covaxin manufacturer, Bharat Biotech, has been submitting data to WHO on a rolling […]

Shortly afer the reports went viral after two major news channels began flashing the news, Bharat Biotech refuted these reports

The process for getting approvals for the indigenous vaccine needs to be expedited to avoid hardships for millions of people

Regulatory approvals for Covaxin are in process in more than 60 countries including USA, Brazil and Hungary, says the Hyderabad company.